tiprankstipranks
Barinthus CSO Nadege Pelletier to depart, Geoffrey Lynn to succeed
PremiumThe FlyBarinthus CSO Nadege Pelletier to depart, Geoffrey Lynn to succeed
3M ago
Barinthus Biotherapeutics Reports Promising IM-PROVE II Trial Results
Premium
Company Announcements
Barinthus Biotherapeutics Reports Promising IM-PROVE II Trial Results
3M ago
Barinthus announces results from ongoing Phase 2b HBV003 trial
Premium
The Fly
Barinthus announces results from ongoing Phase 2b HBV003 trial
3M ago
Barinthus Bio completes enrollment for hepatitis B, prostate cancer trials
PremiumThe FlyBarinthus Bio completes enrollment for hepatitis B, prostate cancer trials
5M ago
Barinthus Biotherapeutics initiates Phase 1 clinical trial of VTP-1000
Premium
The Fly
Barinthus Biotherapeutics initiates Phase 1 clinical trial of VTP-1000
5M ago
Barinthus Biotherapeutics Elevates Griffiths to COO
Premium
Company Announcements
Barinthus Biotherapeutics Elevates Griffiths to COO
6M ago
Barinthus Biotherapeutics to prioritize VTP-300, reduce workforce by 25%
PremiumThe FlyBarinthus Biotherapeutics to prioritize VTP-300, reduce workforce by 25%
9M ago
Barinthus Biotherapeutics Breakthrough in Hepatitis B Treatment
Premium
Company Announcements
Barinthus Biotherapeutics Breakthrough in Hepatitis B Treatment
9M ago
Barinthus presents EOT data from Phase 2a trial of imdusiran, VTP-300
Premium
The Fly
Barinthus presents EOT data from Phase 2a trial of imdusiran, VTP-300
9M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100